Gilead: Crohn's Treatment Is Not The Solution By: TalkMarkets March 24, 2017 at 18:52 PM EDT Gilead is advancing a Crohn's treatment to Phase 2 but even if it passes Phase 3, it won't be the solution to GILD's problems.. Read More >> Related Stocks: Galapagos NV ADR Gilead Sciences